BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27603912)

  • 1. Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors.
    Ham SL; Joshi R; Luker GD; Tavana H
    Adv Healthc Mater; 2016 Nov; 5(21):2788-2798. PubMed ID: 27603912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing.
    Voissiere A; Jouberton E; Maubert E; Degoul F; Peyrode C; Chezal JM; Miot-Noirault É
    PLoS One; 2017; 12(7):e0181340. PubMed ID: 28704566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302.
    Meng F; Evans JW; Bhupathi D; Banica M; Lan L; Lorente G; Duan JX; Cai X; Mowday AM; Guise CP; Maroz A; Anderson RF; Patterson AV; Stachelek GC; Glazer PM; Matteucci MD; Hart CP
    Mol Cancer Ther; 2012 Mar; 11(3):740-51. PubMed ID: 22147748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
    He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
    Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines.
    Fujiwara D; Kato K; Nohara S; Iwanuma Y; Kajiyama Y
    Biochem Biophys Res Commun; 2013 May; 434(4):773-8. PubMed ID: 23602898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line.
    Fang DD; Cao J; Jani JP; Tsaparikos K; Blasina A; Kornmann J; Lira ME; Wang J; Jirout Z; Bingham J; Zhu Z; Gu Y; Los G; Hostomsky Z; Vanarsdale T
    Front Med; 2013 Dec; 7(4):462-76. PubMed ID: 23820871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening.
    Christensen AG; Ehmsen S; Terp MG; Batra R; Alcaraz N; Baumbach J; Noer JB; Moreira J; Leth-Larsen R; Larsen MR; Ditzel HJ
    Stem Cells; 2017 Aug; 35(8):1898-1912. PubMed ID: 28600813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.
    Bao B; Ahmad A; Kong D; Ali S; Azmi AS; Li Y; Banerjee S; Padhye S; Sarkar FH
    PLoS One; 2012; 7(8):e43726. PubMed ID: 22952749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
    Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
    BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells.
    Tudoran O; Soritau O; Balacescu L; Visan S; Barbos O; Cojocneanu-Petric R; Balacescu O; Berindan-Neagoe I
    Mol Cell Biochem; 2015 Nov; 409(1-2):163-76. PubMed ID: 26187676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic printing and drug testing of 384-well tumor spheroids.
    Ham SL; Thakuri PS; Tavana H
    Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():2183-6. PubMed ID: 26736723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.
    Benito J; Ramirez MS; Millward NZ; Velez J; Harutyunyan KG; Lu H; Shi YX; Matre P; Jacamo R; Ma H; Konoplev S; McQueen T; Volgin A; Protopopova M; Mu H; Lee J; Bhattacharya PK; Marszalek JR; Davis RE; Bankson JA; Cortes JE; Hart CP; Andreeff M; Konopleva M
    Clin Cancer Res; 2016 Apr; 22(7):1687-98. PubMed ID: 26603259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
    Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
    Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.
    Kwak JH; Lee NH; Lee HY; Hong IS; Nam JS
    Oncotarget; 2016 Jul; 7(28):43518-43533. PubMed ID: 27270657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.
    Murakami A; Takahashi F; Nurwidya F; Kobayashi I; Minakata K; Hashimoto M; Nara T; Kato M; Tajima K; Shimada N; Iwakami S; Moriyama M; Moriyama H; Koizumi F; Takahashi K
    PLoS One; 2014; 9(1):e86459. PubMed ID: 24489728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy Rescues Hypoxic Tumor Cells and Induces Their Reoxygenation and Repopulation-An Effect That Is Inhibited by the Hypoxia-Activated Prodrug TH-302.
    Saggar JK; Tannock IF
    Clin Cancer Res; 2015 May; 21(9):2107-14. PubMed ID: 25677696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids.
    Kolenda J; Jensen SS; Aaberg-Jessen C; Christensen K; Andersen C; Brünner N; Kristensen BW
    J Neurooncol; 2011 May; 103(1):43-58. PubMed ID: 20835751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
    Saha S; Mukherjee S; Mazumdar M; Manna A; Khan P; Adhikary A; Kajal K; Jana D; Sa G; Mukherjee S; Sarkar DK; Das T
    Transl Res; 2015 May; 165(5):558-77. PubMed ID: 25468484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin 19
    Saha SK; Kim K; Yang GM; Choi HY; Cho SG
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.